Partners HealthCare System has raised has raised $171 million for a second innovation fund targeting seed stage investments in life science startups, according to a news release. The Brigham and Women’s Hospital and Massachusetts General Hospital each committed $50 million for the fund.
The University of Maryland dedicates the new A. James Clark Hall today, a 184,000-square-foot facility that will catalyze engineering innovation and bioengineering breakthroughs and serve as a hub for new partnerships and collaborations throughout the Baltimore-Washington region. A. James Clark Hall is the only space in the nation dedicated to bioengineering and the translation of health-related products that incorporates FDA-funded Centers of Excellence in both Regulatory Science and Pediatric Device Innovation.
M-1 Ventures Demo Day is an event for partners, investors, industry leaders and the press to learn about market-changing technologies and solutions from each of the graduating M-1 startups and get a preview of where each company is headed next.
Johns Hopkins University has unveiled the 2017-2018 cohort of 10 mainly US-based startups to take part in its Social Innovation Lab incubator for non-profit businesses.
Every year, nearly 50,000 research proposals are submitted to the only federal agency in the United States that funds discovery research in all fields of science and engineering: the National Science Foundation (NSF). The agency uses merit review to pick proposals that show the greatest potential to fulfill NSF’s mission to promote the progress of science and serve the national interest.
Recent developments in bioengineering promise the possibility of new diagnostic and treatment strategies, novel industrial processes, and innovative approaches to thorny problems in fields such as nutrition, agriculture, and biomanufacturing. As modern genetics has matured and developed technologies of increasing power, debates over risk assessments and proper applications of the technology, and over who should have decision-making power over such issues, have become more prominent. Recently, some scientists have advocated that ethicists “step out of the way,” whereas others have called for greater ethical scrutiny, or even for moratoria on some lines of research.
Wednesday November 15, 2017 5:00 PM – 7:00 PM
TEDCO IPO Conference Room 7021 Columbia Gateway Suite 200 Columbia, MD 21046
Does your Startup need Funding & Mentorship?
Launch your startup with the FounderTrac Startup Accelerator, a partnership between the MTC, LAUNCH! Annapolis, MCVC Partners and TEDCO.
You can raise capital, learn from a proven curriculum and receive hands-on mentoring from successful entrepreneurs and top executives to scale your company.
The Texas Medical Center, the largest medical complex in the world, today announced the TMC Venture Fund, a $25 million initiative designed to support technologies and early-stage companies to flourish in Houston’s health care ecosystem and further the TMC’s mission to advance health, education and research.
William Osler, often called the father of modern medicine, famously advised his students: “Just listen to your patient; he is telling you the diagnosis.” A century later, clinicians and health system leaders started tuning out the patient’s voice, turning instead to electronic health records and the latest care protocols to manage their most complicated and high-need patients. We believe it’s time for an urgent and strategic reset. The factors that lead people to become our nation’s costliest are complex. But they call for, at the start, the simplest intervention: listening.
Eli Lilly and Company is an innovation-driven biopharmaceutical company that aspires to make a significant contribution to humanity by improving global health in the 21st century. In this article, part of our Biopharma Frontiers series on how the pharmaceutical industry is evolving and how leaders can adapt, David A. Ricks, the chairman and CEO of Eli Lilly, discusses the opportunities and rewards for innovation and the implications for industry business models. This article is an edited summary of his conversation with McKinsey.
